癌症治疗的费用与其治疗效果无关。
The cost of cancer care is not related to its outcomes.
作者信息
Storme Guy, Dhaese S, Corens D, De Ridder Mark
机构信息
Department of Radiation Oncology, UZ Brussel, Belgium.
Financial Department, UZ Brussel, Belgium.
出版信息
Ecancermedicalscience. 2016 Oct 28;10:687. doi: 10.3332/ecancer.2016.687. eCollection 2016.
Abstract
Solid tumours make up 90% of all proliferative diseases and the main action for cure remains surgery, removing the visible tumour as well as the surrounding tissue. Radiotherapy is an added value for eliminating local microscopic as well as regional disease. Systemic treatment has a small impact on the outcome but has a cost, which is as much as all the other actions such as diagnostic tools and treatments.
摘要
实体瘤占所有增殖性疾病的90%，治愈的主要方法仍然是手术，切除可见肿瘤以及周围组织。放射治疗对于消除局部微小病变和区域性疾病具有附加价值。全身治疗对治疗结果的影响较小，但有成本，其成本与诊断工具和治疗等所有其他措施的成本一样高。
相似文献
1
The cost of cancer care is not related to its outcomes.癌症治疗的费用与其治疗效果无关。
Ecancermedicalscience. 2016 Oct 28;10:687. doi: 10.3332/ecancer.2016.687. eCollection 2016.
2
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益：一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions.瑞典医疗技术评估委员会（SBU）对某些主要肿瘤类型化疗效果的系统综述——总结与结论
Acta Oncol. 2001;40(2-3):135-54. doi: 10.1080/02841860151116169.
5
The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.用于早期乳腺癌辅助治疗的INTRABEAM®光子放射治疗系统：系统评价与经济评估
Health Technol Assess. 2015 Aug;19(69):1-190. doi: 10.3310/hta19690.
6
A systematic overview of radiation therapy effects in soft tissue sarcomas.软组织肉瘤放射治疗效果的系统综述。
Acta Oncol. 2003;42(5-6):516-31. doi: 10.1080/02841860310014732.
7
Post-treatment complications of soft tissue tumours.软组织肿瘤的治疗后并发症
Eur J Radiol. 2009 Feb;69(2):209-21. doi: 10.1016/j.ejrad.2008.10.008. Epub 2008 Dec 19.
8
Curative and palliative aspects of regional chemotherapy in combination with surgery.区域化疗联合手术的治疗与姑息治疗方面
Support Care Cancer. 2003 Jan;11(1):1-10. doi: 10.1007/s00520-002-0355-2. Epub 2002 Jun 8.
9
The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial.I期乳腺癌区段切除及腋窝淋巴结清扫术后常规放疗的成本效益。一项随机试验的结果。
Ann Oncol. 1997 Aug;8(8):757-63. doi: 10.1023/a:1008230000822.
10
Radiotherapy versus surgery for early T1-T2 glottic carcinoma.早期T1-T2声门癌的放射治疗与手术治疗对比
J Otolaryngol. 2006 Dec;35(6):413-9. doi: 10.2310/7070.2005.0036.
引用本文的文献
1
Is there any benefit to particles over photon radiotherapy?粒子放疗相对于光子放疗有什么优势吗？
Ecancermedicalscience. 2019 Dec 9;13:982. doi: 10.3332/ecancer.2019.982. eCollection 2019.
本文引用的文献
1
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.纳武利尤单抗与伊匹木单抗联合用药对比伊匹木单抗单药治疗晚期黑色素瘤患者：一项多中心、随机、对照、2期试验的2年总生存结果
Lancet Oncol. 2016 Nov;17(11):1558-1568. doi: 10.1016/S1470-2045(16)30366-7. Epub 2016 Sep 9.
2
Perspective: The precision-oncology illusion.观点：精准肿瘤学的错觉。
Nature. 2016 Sep 8;537(7619):S63. doi: 10.1038/537S63a.
3
The Value of Considering Cost, and the Cost of Not Considering Value.考虑成本的价值，以及不考虑价值的代价。
J Clin Oncol. 2016 Mar 1;34(7):659-60. doi: 10.1200/JCO.2015.64.7867. Epub 2015 Dec 14.
4
Characteristics of Exceptional or Super Responders to Cancer Drugs.癌症药物的卓越或超强应答者的特征。
Mayo Clin Proc. 2015 Dec;90(12):1639-49. doi: 10.1016/j.mayocp.2015.08.017. Epub 2015 Nov 3.
5
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.基于肿瘤分子谱的分子靶向治疗与晚期癌症的常规治疗（SHIVA）：一项多中心、开放标签、概念验证、随机、对照的 2 期临床试验。
Lancet Oncol. 2015 Oct;16(13):1324-34. doi: 10.1016/S1470-2045(15)00188-6. Epub 2015 Sep 3.
6
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.保乳手术后早期乳腺癌患者行全乳放疗或加量放疗：一项随机 3 期临床试验 20 年随访结果
Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9.
7
Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer.立体定向体部放疗中呼吸运动管理不足对寡转移结直肠癌的影响。
Radiother Oncol. 2014 Nov;113(2):235-9. doi: 10.1016/j.radonc.2014.11.005. Epub 2014 Nov 28.
8
Parotid gland sparing with helical tomotherapy in head-and-neck cancer.螺旋断层放疗在头颈部肿瘤中保腮腺。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):443-8. doi: 10.1016/j.ijrobp.2011.11.070. Epub 2012 Jul 25.
9
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial.前列腺癌的低分割高剂量放射治疗：多机构 II 期试验的长期结果。
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e483-90. doi: 10.1016/j.ijrobp.2012.04.012. Epub 2012 Jun 5.
10
Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.术前螺旋断层放疗同步推量治疗直肠癌的 II 期研究。
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):142-8. doi: 10.1016/j.ijrobp.2011.05.068. Epub 2011 Oct 17.
Zotero 插件